Document is current

Any future updates will be listed below

Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer

Crossref DOI link: https://doi.org/10.1007/s10637-014-0112-7

Published Online: 2014-05-31

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark